XML 96 R81.htm IDEA: XBRL DOCUMENT v3.23.1
Business Segment Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Jun. 02, 2021
Segment Reporting Information [Line Items]        
amortization of inventory and property step up to fair value [1] $ 12,254 $ 81,804 $ 5,600  
amortization and impairment of acquired intangible assets [1] 376,822 366,434 83,892  
Business Combination, Acquisition Related Costs [2] 24,196 205,788 35,634  
loss (gain) on fair value contingent consideration adjustments [1] (3,100) (2,350) (500)  
Gain (Loss) on Disposition of Business [1] (67) (874) 2,030  
COVID-19 incremental costs [3] 0 0 25,793  
redomiciliation costs [4] 661 301 1,592  
Restructuring expenses [5] 485 48 (3,029)  
Assets 10,821,839 11,423,594    
Payments to Acquire Productive Assets 361,969 287,563 239,262  
Depreciation, Depletion and Amortization 552,897 553,104 [6] 219,237  
Property, Plant and Equipment, Net 1,705,512 1,552,576    
Revenues 4,957,839 4,585,064 3,107,519  
Operating Income (Loss) 268,185 425,618 548,368  
Contingent Consideration Liability Assumed in Cantel Combination   25,000   $ 25,000
Goodwill, Impairment Loss [7] 490,565 0 0  
Healthcare [Member]        
Segment Reporting Information [Line Items]        
Revenues 3,085,131 2,845,467 1,954,055  
Operating Income (Loss) 706,020 649,704 427,089  
Goodwill, Impairment Loss 0      
Healthcare and Life Sciences [Member]        
Segment Reporting Information [Line Items]        
Assets 6,538,270 6,604,893    
Payments to Acquire Productive Assets 98,585 84,487 74,446  
Depreciation, Depletion and Amortization 306,377 316,222 [6] 106,266  
Amortization of Acquired Intangibles and PPE Step Up   229,052    
Applied Sterilization Technologies [Member]        
Segment Reporting Information [Line Items]        
Assets 3,124,341 3,053,116    
Payments to Acquire Productive Assets 253,914 198,350 164,816  
Depreciation, Depletion and Amortization 116,153 115,925 [6] 112,971  
Revenues 914,431 852,972 685,912  
Operating Income (Loss) 429,020 410,101 310,648  
Amortization of Acquired Intangibles and PPE Step Up   35,531    
Goodwill, Impairment Loss 0      
Dental        
Segment Reporting Information [Line Items]        
Assets 1,159,228 1,765,585    
Payments to Acquire Productive Assets 9,470 4,726 0  
Depreciation, Depletion and Amortization 130,367 120,957 [6] 0  
Revenues 421,573 361,661 0  
Operating Income (Loss) 89,527 84,441 0  
Amortization of Acquired Intangibles and PPE Step Up   $ 113,099    
Goodwill, Impairment Loss $ 490,565      
Dental | Revenue Benchmark | Customer Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration Risk, Percentage 47.40% 45.10%    
Historical Average Percentage of Concentration Risk 40.00%      
OperatingSegmentAllExceptCorpandOther [Member]        
Segment Reporting Information [Line Items]        
Revenues $ 4,957,839 $ 4,585,064 3,107,519  
Life Science Member [Member]        
Segment Reporting Information [Line Items]        
Revenues 536,704 524,964 467,552  
Operating Income (Loss) 210,225 216,188 180,796  
OperatingSegmentCorpandOther [Member]        
Segment Reporting Information [Line Items]        
Operating Income (Loss) (264,791) (283,665) (219,153)  
OperatingSegmentAll [Member]        
Segment Reporting Information [Line Items]        
Revenues 4,957,839 4,585,064 3,107,519  
Operating Income (Loss) 1,170,001 1,076,769 699,380  
Adjustments to Liability        
Segment Reporting Information [Line Items]        
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (3,100)      
Additions [Member]        
Segment Reporting Information [Line Items]        
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 8,302 601    
Reductions and Payout        
Segment Reporting Information [Line Items]        
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (80) (32,336)    
Consumable revenues [Member] | Healthcare [Member]        
Segment Reporting Information [Line Items]        
Revenues 1,050,316 1,004,605 510,946  
Consumable revenues [Member] | Life Science Member [Member]        
Segment Reporting Information [Line Items]        
Revenues 241,114 239,365 215,005  
Capital equipment revenues [Member] | Healthcare [Member]        
Segment Reporting Information [Line Items]        
Revenues 896,590 782,505 588,864  
Capital equipment revenues [Member] | Applied Sterilization Technologies [Member]        
Segment Reporting Information [Line Items]        
Revenues 26,460 24,394 0  
Capital equipment revenues [Member] | Life Science Member [Member]        
Segment Reporting Information [Line Items]        
Revenues 147,420 142,281 128,356  
Service revenues [Member] | Healthcare [Member]        
Segment Reporting Information [Line Items]        
Revenues 1,138,225 1,058,357 854,245  
Service revenues [Member] | Applied Sterilization Technologies [Member]        
Segment Reporting Information [Line Items]        
Revenues 887,971 828,578 685,912  
Service revenues [Member] | Life Science Member [Member]        
Segment Reporting Information [Line Items]        
Revenues 148,170 143,318 124,191  
IRELAND        
Segment Reporting Information [Line Items]        
Property, Plant and Equipment, Net 60,570 60,275    
Revenues 74,463 82,011 71,905  
UNITED STATES        
Segment Reporting Information [Line Items]        
Property, Plant and Equipment, Net 946,930 881,057    
Revenues 3,586,486 3,228,864 2,227,038  
Other foreign locations [Member]        
Segment Reporting Information [Line Items]        
Revenues 1,296,890 1,274,189 $ 808,576  
Other Foreign Entities [Member]        
Segment Reporting Information [Line Items]        
Property, Plant and Equipment, Net $ 698,012 $ 611,244    
[1] For more information regarding our recent acquisitions and divestitures, refer to Note 2 titled, "Business Acquisitions and Divestitures."
[2] Acquisition and integration related charges include transaction costs and integration expenses associated with acquisitions.
[3] COVID-19 incremental costs includes the additional costs attributable to COVID-19 such as enhanced cleaning protocols, personal protective equipment for our employees, event cancellation fees, and payroll costs associated with our response to COVID-19, net of any government subsidies available.
[4] Costs incurred in tax restructuring.
[5] For more information regarding our restructuring efforts, refer to our Annual Report on Form 10-K for the year ended March 31, 2021, dated May 28, 2021.
[6] Fiscal 2022 totals include approximately $229,052, $35,531 and $113,099 for Healthcare and Life Sciences, Applied Sterilization Technologies, and Dental, respectively, of amortization of acquired intangible assets and amortization of property "step-up" to fair value. For more information regarding our recent acquisitions and divestitures see Note 2 titled, "Business Acquisitions and Divestitures."
[7] For more information regarding our goodwill impairment loss, refer to Note 3 titled, "Goodwill and Intangible Assets."